Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation

Background Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder most often caused by mutation in the endoglin or ALK1 genes. A distinct syndrome combines the clinical features of HHT and juvenile polyposis (JP) and has been associated with SMAD4 mutation. The aim of this stu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of gastroenterology 2012-07, Vol.47 (7), p.795-804
Hauptverfasser: Schwenter, Frank, Faughnan, Marie E., Gradinger, Abigail B., Berk, Terri, Gryfe, Robert, Pollett, Aaron, Cohen, Zane, Gallinger, Steven, Durno, Carol
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 804
container_issue 7
container_start_page 795
container_title Journal of gastroenterology
container_volume 47
creator Schwenter, Frank
Faughnan, Marie E.
Gradinger, Abigail B.
Berk, Terri
Gryfe, Robert
Pollett, Aaron
Cohen, Zane
Gallinger, Steven
Durno, Carol
description Background Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder most often caused by mutation in the endoglin or ALK1 genes. A distinct syndrome combines the clinical features of HHT and juvenile polyposis (JP) and has been associated with SMAD4 mutation. The aim of this study was to describe the phenotype of patients with JP–HHT and SMAD4 mutations and to compare this phenotype with HHT or JP patients with mutations other than SMAD4 . Methods Patients prospectively enrolled in the Toronto HHT and JP databases who underwent genotyping were included. The phenotypic characteristics of JP–HHT patients with SMAD4 mutations and patients with mutations other than SMAD4 were analyzed and compared. Results Three hundred and fifty-eight patients underwent genetic testing (HHT, n  = 332; JP, n  = 26). Among fourteen patients identified with SMAD4 mutations, ten met the clinical diagnostic criteria for both JP and HHT (71%). Patients with SMAD4 mutations had 100% penetrance of the polyposis phenotype. All patients with JP and SMAD4 mutation had features of HHT. Three JP–HHT patients developed early onset colorectal cancer (CRC) (mean age 28 years). JP–HHT patients with SMAD4 mutation had a significantly higher rate of anemia than HHT patients with mutations other than SMAD4 . Conclusions Patients with HHT and SMAD4 mutations are at significant risk of JP and CRC. The gastrointestinal phenotype is similar to JP patients without SMAD4 mutation. It is essential for HHT patients to undergo genetic testing to determine if they have SMAD4 mutations so that appropriate gastrointestinal screening and surveillance for JP and CRC can be completed.
doi_str_mv 10.1007/s00535-012-0545-8
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1753494989</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A714585945</galeid><sourcerecordid>A714585945</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-cc0c0e8dcf1decabe1f1d9abbfd390a1c56041dec577330e6304b026f2b96183</originalsourceid><addsrcrecordid>eNqFUsuO1DAQtBCIHQY-gAuyxIXDZmnHdh7H0fLWIg7s3XKczoxXiR1sBzQSH4-jWZ4CIR_c6q4qu7uLkMcMLhhA_TwCSC4LYGUBUsiiuUM2TOSMbMvyLtlAK0TBWC3OyIMYbwAYB9ncJ2dlyTnjVbUhX98tn9HZEensx-Pso43n9IABe5t0OOZw8iEc9N4amnDUbm_RJB2tPqfa9RR1GI_Uu4iJGj_6sFZHarQzGKh1dNbJokuRfrHpQD--370QdFpSznr3kNwb9Bjx0e29JdevXl5fvimuPrx-e7m7KowsZSqMAQPY9GZgPRrdIctBq7tu6HkLmhlZgVhLsq45B6w4iA7Kaii7tmIN35JnJ9k5-E8LxqQmGw2OuRv0S1Sslly0om3a_0OhrHnNITO25Okf0Bu_BJf7WFFVI_OQ2U_UXo-orBt8CtqsompXMyEb2YpV6-IvqHx6nKzxDoe8od8J7EQwwccYcFBzsFNeWH5brd5QJ2-o7A21ekOtY3hy--Glm7D_wfhuhgwoT4CYS26P4deO_qX6DftQw9U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1026852231</pqid></control><display><type>article</type><title>Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Schwenter, Frank ; Faughnan, Marie E. ; Gradinger, Abigail B. ; Berk, Terri ; Gryfe, Robert ; Pollett, Aaron ; Cohen, Zane ; Gallinger, Steven ; Durno, Carol</creator><creatorcontrib>Schwenter, Frank ; Faughnan, Marie E. ; Gradinger, Abigail B. ; Berk, Terri ; Gryfe, Robert ; Pollett, Aaron ; Cohen, Zane ; Gallinger, Steven ; Durno, Carol</creatorcontrib><description>Background Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder most often caused by mutation in the endoglin or ALK1 genes. A distinct syndrome combines the clinical features of HHT and juvenile polyposis (JP) and has been associated with SMAD4 mutation. The aim of this study was to describe the phenotype of patients with JP–HHT and SMAD4 mutations and to compare this phenotype with HHT or JP patients with mutations other than SMAD4 . Methods Patients prospectively enrolled in the Toronto HHT and JP databases who underwent genotyping were included. The phenotypic characteristics of JP–HHT patients with SMAD4 mutations and patients with mutations other than SMAD4 were analyzed and compared. Results Three hundred and fifty-eight patients underwent genetic testing (HHT, n  = 332; JP, n  = 26). Among fourteen patients identified with SMAD4 mutations, ten met the clinical diagnostic criteria for both JP and HHT (71%). Patients with SMAD4 mutations had 100% penetrance of the polyposis phenotype. All patients with JP and SMAD4 mutation had features of HHT. Three JP–HHT patients developed early onset colorectal cancer (CRC) (mean age 28 years). JP–HHT patients with SMAD4 mutation had a significantly higher rate of anemia than HHT patients with mutations other than SMAD4 . Conclusions Patients with HHT and SMAD4 mutations are at significant risk of JP and CRC. The gastrointestinal phenotype is similar to JP patients without SMAD4 mutation. It is essential for HHT patients to undergo genetic testing to determine if they have SMAD4 mutations so that appropriate gastrointestinal screening and surveillance for JP and CRC can be completed.</description><identifier>ISSN: 0944-1174</identifier><identifier>EISSN: 1435-5922</identifier><identifier>DOI: 10.1007/s00535-012-0545-8</identifier><identifier>PMID: 22331366</identifier><language>eng</language><publisher>Japan: Springer Japan</publisher><subject>Abdominal Surgery ; Adolescent ; Adult ; Age of Onset ; Analysis ; Anemia ; Cancer patients ; Care and treatment ; Child ; Colorectal cancer ; Colorectal Neoplasms - genetics ; Colorectal Surgery ; Databases, Factual ; Development and progression ; Gastroenterology ; Genetic aspects ; Genetic Testing ; Hepatology ; Humans ; Intestinal Polyposis - congenital ; Intestinal Polyposis - genetics ; Medicine ; Medicine &amp; Public Health ; Mutation ; Neoplastic Syndromes, Hereditary - genetics ; Ontario ; Original Article—Alimentary Tract ; Prospective Studies ; Smad4 Protein - genetics ; Surgical Oncology ; Telangiectasia, Hereditary Hemorrhagic - genetics ; Telangiectasis ; Young Adult</subject><ispartof>Journal of gastroenterology, 2012-07, Vol.47 (7), p.795-804</ispartof><rights>Springer 2012</rights><rights>COPYRIGHT 2012 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-cc0c0e8dcf1decabe1f1d9abbfd390a1c56041dec577330e6304b026f2b96183</citedby><cites>FETCH-LOGICAL-c525t-cc0c0e8dcf1decabe1f1d9abbfd390a1c56041dec577330e6304b026f2b96183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00535-012-0545-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00535-012-0545-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22331366$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schwenter, Frank</creatorcontrib><creatorcontrib>Faughnan, Marie E.</creatorcontrib><creatorcontrib>Gradinger, Abigail B.</creatorcontrib><creatorcontrib>Berk, Terri</creatorcontrib><creatorcontrib>Gryfe, Robert</creatorcontrib><creatorcontrib>Pollett, Aaron</creatorcontrib><creatorcontrib>Cohen, Zane</creatorcontrib><creatorcontrib>Gallinger, Steven</creatorcontrib><creatorcontrib>Durno, Carol</creatorcontrib><title>Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation</title><title>Journal of gastroenterology</title><addtitle>J Gastroenterol</addtitle><addtitle>J Gastroenterol</addtitle><description>Background Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder most often caused by mutation in the endoglin or ALK1 genes. A distinct syndrome combines the clinical features of HHT and juvenile polyposis (JP) and has been associated with SMAD4 mutation. The aim of this study was to describe the phenotype of patients with JP–HHT and SMAD4 mutations and to compare this phenotype with HHT or JP patients with mutations other than SMAD4 . Methods Patients prospectively enrolled in the Toronto HHT and JP databases who underwent genotyping were included. The phenotypic characteristics of JP–HHT patients with SMAD4 mutations and patients with mutations other than SMAD4 were analyzed and compared. Results Three hundred and fifty-eight patients underwent genetic testing (HHT, n  = 332; JP, n  = 26). Among fourteen patients identified with SMAD4 mutations, ten met the clinical diagnostic criteria for both JP and HHT (71%). Patients with SMAD4 mutations had 100% penetrance of the polyposis phenotype. All patients with JP and SMAD4 mutation had features of HHT. Three JP–HHT patients developed early onset colorectal cancer (CRC) (mean age 28 years). JP–HHT patients with SMAD4 mutation had a significantly higher rate of anemia than HHT patients with mutations other than SMAD4 . Conclusions Patients with HHT and SMAD4 mutations are at significant risk of JP and CRC. The gastrointestinal phenotype is similar to JP patients without SMAD4 mutation. It is essential for HHT patients to undergo genetic testing to determine if they have SMAD4 mutations so that appropriate gastrointestinal screening and surveillance for JP and CRC can be completed.</description><subject>Abdominal Surgery</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Age of Onset</subject><subject>Analysis</subject><subject>Anemia</subject><subject>Cancer patients</subject><subject>Care and treatment</subject><subject>Child</subject><subject>Colorectal cancer</subject><subject>Colorectal Neoplasms - genetics</subject><subject>Colorectal Surgery</subject><subject>Databases, Factual</subject><subject>Development and progression</subject><subject>Gastroenterology</subject><subject>Genetic aspects</subject><subject>Genetic Testing</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Intestinal Polyposis - congenital</subject><subject>Intestinal Polyposis - genetics</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mutation</subject><subject>Neoplastic Syndromes, Hereditary - genetics</subject><subject>Ontario</subject><subject>Original Article—Alimentary Tract</subject><subject>Prospective Studies</subject><subject>Smad4 Protein - genetics</subject><subject>Surgical Oncology</subject><subject>Telangiectasia, Hereditary Hemorrhagic - genetics</subject><subject>Telangiectasis</subject><subject>Young Adult</subject><issn>0944-1174</issn><issn>1435-5922</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFUsuO1DAQtBCIHQY-gAuyxIXDZmnHdh7H0fLWIg7s3XKczoxXiR1sBzQSH4-jWZ4CIR_c6q4qu7uLkMcMLhhA_TwCSC4LYGUBUsiiuUM2TOSMbMvyLtlAK0TBWC3OyIMYbwAYB9ncJ2dlyTnjVbUhX98tn9HZEensx-Pso43n9IABe5t0OOZw8iEc9N4amnDUbm_RJB2tPqfa9RR1GI_Uu4iJGj_6sFZHarQzGKh1dNbJokuRfrHpQD--370QdFpSznr3kNwb9Bjx0e29JdevXl5fvimuPrx-e7m7KowsZSqMAQPY9GZgPRrdIctBq7tu6HkLmhlZgVhLsq45B6w4iA7Kaii7tmIN35JnJ9k5-E8LxqQmGw2OuRv0S1Sslly0om3a_0OhrHnNITO25Okf0Bu_BJf7WFFVI_OQ2U_UXo-orBt8CtqsompXMyEb2YpV6-IvqHx6nKzxDoe8od8J7EQwwccYcFBzsFNeWH5brd5QJ2-o7A21ekOtY3hy--Glm7D_wfhuhgwoT4CYS26P4deO_qX6DftQw9U</recordid><startdate>20120701</startdate><enddate>20120701</enddate><creator>Schwenter, Frank</creator><creator>Faughnan, Marie E.</creator><creator>Gradinger, Abigail B.</creator><creator>Berk, Terri</creator><creator>Gryfe, Robert</creator><creator>Pollett, Aaron</creator><creator>Cohen, Zane</creator><creator>Gallinger, Steven</creator><creator>Durno, Carol</creator><general>Springer Japan</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20120701</creationdate><title>Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation</title><author>Schwenter, Frank ; Faughnan, Marie E. ; Gradinger, Abigail B. ; Berk, Terri ; Gryfe, Robert ; Pollett, Aaron ; Cohen, Zane ; Gallinger, Steven ; Durno, Carol</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-cc0c0e8dcf1decabe1f1d9abbfd390a1c56041dec577330e6304b026f2b96183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Abdominal Surgery</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Age of Onset</topic><topic>Analysis</topic><topic>Anemia</topic><topic>Cancer patients</topic><topic>Care and treatment</topic><topic>Child</topic><topic>Colorectal cancer</topic><topic>Colorectal Neoplasms - genetics</topic><topic>Colorectal Surgery</topic><topic>Databases, Factual</topic><topic>Development and progression</topic><topic>Gastroenterology</topic><topic>Genetic aspects</topic><topic>Genetic Testing</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Intestinal Polyposis - congenital</topic><topic>Intestinal Polyposis - genetics</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mutation</topic><topic>Neoplastic Syndromes, Hereditary - genetics</topic><topic>Ontario</topic><topic>Original Article—Alimentary Tract</topic><topic>Prospective Studies</topic><topic>Smad4 Protein - genetics</topic><topic>Surgical Oncology</topic><topic>Telangiectasia, Hereditary Hemorrhagic - genetics</topic><topic>Telangiectasis</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schwenter, Frank</creatorcontrib><creatorcontrib>Faughnan, Marie E.</creatorcontrib><creatorcontrib>Gradinger, Abigail B.</creatorcontrib><creatorcontrib>Berk, Terri</creatorcontrib><creatorcontrib>Gryfe, Robert</creatorcontrib><creatorcontrib>Pollett, Aaron</creatorcontrib><creatorcontrib>Cohen, Zane</creatorcontrib><creatorcontrib>Gallinger, Steven</creatorcontrib><creatorcontrib>Durno, Carol</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Journal of gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schwenter, Frank</au><au>Faughnan, Marie E.</au><au>Gradinger, Abigail B.</au><au>Berk, Terri</au><au>Gryfe, Robert</au><au>Pollett, Aaron</au><au>Cohen, Zane</au><au>Gallinger, Steven</au><au>Durno, Carol</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation</atitle><jtitle>Journal of gastroenterology</jtitle><stitle>J Gastroenterol</stitle><addtitle>J Gastroenterol</addtitle><date>2012-07-01</date><risdate>2012</risdate><volume>47</volume><issue>7</issue><spage>795</spage><epage>804</epage><pages>795-804</pages><issn>0944-1174</issn><eissn>1435-5922</eissn><abstract>Background Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder most often caused by mutation in the endoglin or ALK1 genes. A distinct syndrome combines the clinical features of HHT and juvenile polyposis (JP) and has been associated with SMAD4 mutation. The aim of this study was to describe the phenotype of patients with JP–HHT and SMAD4 mutations and to compare this phenotype with HHT or JP patients with mutations other than SMAD4 . Methods Patients prospectively enrolled in the Toronto HHT and JP databases who underwent genotyping were included. The phenotypic characteristics of JP–HHT patients with SMAD4 mutations and patients with mutations other than SMAD4 were analyzed and compared. Results Three hundred and fifty-eight patients underwent genetic testing (HHT, n  = 332; JP, n  = 26). Among fourteen patients identified with SMAD4 mutations, ten met the clinical diagnostic criteria for both JP and HHT (71%). Patients with SMAD4 mutations had 100% penetrance of the polyposis phenotype. All patients with JP and SMAD4 mutation had features of HHT. Three JP–HHT patients developed early onset colorectal cancer (CRC) (mean age 28 years). JP–HHT patients with SMAD4 mutation had a significantly higher rate of anemia than HHT patients with mutations other than SMAD4 . Conclusions Patients with HHT and SMAD4 mutations are at significant risk of JP and CRC. The gastrointestinal phenotype is similar to JP patients without SMAD4 mutation. It is essential for HHT patients to undergo genetic testing to determine if they have SMAD4 mutations so that appropriate gastrointestinal screening and surveillance for JP and CRC can be completed.</abstract><cop>Japan</cop><pub>Springer Japan</pub><pmid>22331366</pmid><doi>10.1007/s00535-012-0545-8</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0944-1174
ispartof Journal of gastroenterology, 2012-07, Vol.47 (7), p.795-804
issn 0944-1174
1435-5922
language eng
recordid cdi_proquest_miscellaneous_1753494989
source MEDLINE; SpringerNature Journals
subjects Abdominal Surgery
Adolescent
Adult
Age of Onset
Analysis
Anemia
Cancer patients
Care and treatment
Child
Colorectal cancer
Colorectal Neoplasms - genetics
Colorectal Surgery
Databases, Factual
Development and progression
Gastroenterology
Genetic aspects
Genetic Testing
Hepatology
Humans
Intestinal Polyposis - congenital
Intestinal Polyposis - genetics
Medicine
Medicine & Public Health
Mutation
Neoplastic Syndromes, Hereditary - genetics
Ontario
Original Article—Alimentary Tract
Prospective Studies
Smad4 Protein - genetics
Surgical Oncology
Telangiectasia, Hereditary Hemorrhagic - genetics
Telangiectasis
Young Adult
title Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A36%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Juvenile%20polyposis,%20hereditary%20hemorrhagic%20telangiectasia,%20and%20early%20onset%20colorectal%20cancer%20in%20patients%20with%20SMAD4%20mutation&rft.jtitle=Journal%20of%20gastroenterology&rft.au=Schwenter,%20Frank&rft.date=2012-07-01&rft.volume=47&rft.issue=7&rft.spage=795&rft.epage=804&rft.pages=795-804&rft.issn=0944-1174&rft.eissn=1435-5922&rft_id=info:doi/10.1007/s00535-012-0545-8&rft_dat=%3Cgale_proqu%3EA714585945%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1026852231&rft_id=info:pmid/22331366&rft_galeid=A714585945&rfr_iscdi=true